Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027?
One-OffHealth & MedicineScience1a
Manifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelle
Non 76.9%
Prévisionnistes
7
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 18 heures
Obsolète17 janv. 24, 01:47 UTC1 janv. 28, 04:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will China have more phase 3 drug trials than the United States in year X?
Manifold MarketsWill BioAge's BGE-102 achieve its primary endpoint in the Phase 2 QUELL-CV trial before January 1, 2028?
Manifold MarketsIf I choose to undergo past life regression therapy, what will I have been?
Manifold MarketsTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurHow many clinical trials will have started in Prospera by Dec 31, 2026?
FutuurWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiRègles
Les critères de résolution ne sont pas encore disponibles pour ce marché. Cette section sera remplie lors des prochains rafraîchissements une fois les règles de la source enregistrées.
Marchés ouverts
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.3pt97%
- Yes+0.3pt3%
- Volume total
- 15,6 M €
- Volume 24h
- 35,6 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.9pt3%
- Volume total
- 1,6 M €
- Volume 24h
- 5,2 k €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Volume total
- 83,5 k €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt96%
- Above 6000-4.0pt58%
+2 résultats de plus
- Volume total
- 864,2 k €
- Volume 24h
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- 915,8 k €
- Volume 24h
- 1,5 k €
KALSHIWhen will the FDA approve Intellia Therapeutics' lonvo-z?
- Before July 2027+67.0pt97%
- Before 202872%
- Before October 202752%
- Volume total
- 4,2 k €
- Volume 24h
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- When will the FDA reclassify BPC-157 to Category 1?
- Ebola pandemic in 2026?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- Will the FDA approve CagriSema?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? ?
- Manifold Markets cote No à 77% au 8 septembre 2026.
- Quand Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? sera-t-il résolu ?
- Will Deuterated N,N-Dimethyltryptamine undergo phase III trials by EOY 2027? doit être résolu le 1 janvier 2028.